Clinical trial
Levetiracetam Administration for the Management of Levodopa-Induced Dyskinesias…
NCT00291733 · 1st Hospital of Social Security Services, Other · Unknown status
Key facts
| NCT number | NCT00291733 |
|---|---|
| Title | Levetiracetam Administration for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease |
| Official title | Levetiracetam Administration for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease: A Double-Blind,Placebo-Controlled, Crossover Trial |
| Lead sponsor | 1st Hospital of Social Security Services, Other |
| Collaborators | UCB Pharma Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Levodopa Induced Dyskinesia |
| Intervention type | Drug |
| Interventions | Levetiracetam, Placebo |
| Enrollment | 50 |
| Start date | May 1, 2006 |
| Completion | Oct 1, 2007 |
| First posted | Feb 15, 2006 |
| Last update posted | Nov 15, 2007 |
| Countries | Greece |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: